Report Feature
Immunofluorescence Assay Market Trends and Forecast
The future of the global immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers. The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of CAGR of 5.9% from 2023 to 2028. The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Immunofluorescence Assay Market by Segment
The study includes trends and forecast for the global immunofluorescence assay market by type, product, disease, end use, and region, as follows:
Immunofluorescence Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Indirect Immunofluorescence
- Direct Immunofluorescence
Immunofluorescence Assay Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Antibodies
- Reagents
- Kits
- Instruments
- Consumables and Accessories
Immunofluorescence Assay Market by Disease [Value ($B) Shipment Analysis from 2017 to 2028]:
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Other
Immunofluorescence Assay Market by End Use [Value ($B) Shipment Analysis from 2017 to 2028]:
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Hospitals & Diagnostic Centers
Immunofluorescence Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Immunofluorescence Assay Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunofluorescence assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the immunofluorescence assay companies profiled in this report include-
Immunofluorescence Assay Market Insights
- Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.
- Within this market, the pharmaceutical & biotechnology companies are expected to witness the highest growth over the forecast period due to increasing use of these assays in the study of various diseases and drug discovery & development processes.
- North America is expected to witness the highest growth over the forecast period due to rising incidence of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of major key players in the region.
Features of the Immunofluorescence Assay Market
- Market Size Estimates: Immunofluorescence assay market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Immunofluorescence assay market size by various segments, such as type, product, disease, end use, and region
- Regional Analysis: Immunofluorescence assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, products, diseases, end uses, and regions for the immunofluorescence assay market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the immunofluorescence assay market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the immunofluorescence assay market size?
Answer: The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for immunofluorescence assay market?
Answer: The global immunofluorescence assay market is expected to grow with a CAGR of 5.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the immunofluorescence assay market?
Answer: The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.
Q4. What are the major segments for immunofluorescence assay market?
Answer: The future of the immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers.
Q5. Who are the key immunofluorescence assay companies?
Answer: Some of the key immunofluorescence assay companies are as follows:
Answer: The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for immunofluorescence assay market?
Answer: The global immunofluorescence assay market is expected to grow with a CAGR of 5.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the immunofluorescence assay market?
Answer: The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.
Q4. What are the major segments for immunofluorescence assay market?
Answer: The future of the immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers.
Q5. Who are the key immunofluorescence assay companies?
Answer: Some of the key immunofluorescence assay companies are as follows:
- Thermo Fisher Scientific
- Abcam
- Bio-Rad Laboratories
- Becton Dickinson and Company
- Nikon Corporation
Q6. Which immunofluorescence assay segment will be the largest in future?
Answer: Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.
Q7. In immunofluorescence assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to rising incidence of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of major key players in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.
Q7. In immunofluorescence assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to rising incidence of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of major key players in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
